Regeneron Pharmaceuticals

REGN

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities (thus the name), it branched out into the study of both cytokine and tyrosine kinase receptors.

Regeneron Pharmaceuticals has been a target of short sellers for a while. The current short interest of 2.52% is roughly at the average of the last 12 months (2.75%).